or Try an Advanced Search...

    Technical Analysis for EWTX - Edgewise Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 17.13 -2.11% -0.37
    EWTX closed down 2.11 percent on Friday, May 31, 2024, on 1.56 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical EWTX trend table...
    Date Alert Name Type % Chg
    Fell Below 50 DMA Bearish 0.00%
    180 Bearish Setup Bearish Swing Setup 0.00%
    Outside Day Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Crossed Above 50 DMA Bullish -2.11%
    Stochastic Buy Signal Bullish -2.11%
    Up 3 Days in a Row Strength -2.11%
    Oversold Stochastic Weakness -2.11%
    MACD Bearish Centerline Cross Bearish -0.41%
    Gapped Down Weakness -0.41%
    Older End-of-Day Signals for EWTX ...

       Recent Intraday Alerts

    Alert Time
    Down 1% 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    50 DMA Support 2 days ago
    Fell Below 50 DMA 2 days ago
    Up 2% 2 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    EWTX Chart by TradingView
    Basic chart:

    Profile

    Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. It offers a precision medicine muscle platform that generates programs to address various muscle disorders, such as Duchenne, Becker, and limb girdle muscular dystrophies. The company develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was founded in 2017 and is headquartered in Boulder, Colorado.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Muscular Dystrophy Small Molecule Therapies Limb Girdle Muscular Dystrophies Muscle Disorders

    Is EWTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 10 Edgewise: Intriguing Drug Candidate, But Consider Selling After Recent Run
    May 10 Edgewise Therapeutics Inc (EWTX) Reports First Quarter 2024 Financial Results
    May 10 Edgewise Therapeutics files mixed securities shelf
    May 10 Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024
    May 9 Edgewise Therapeutics GAAP EPS of -$0.33
    May 9 Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
    May 9 Edgewise Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
    May 7 Edgewise Therapeutics Appoints Arlene Morris to its Board of Directors
    May 7 Edgewise Therapeutics doses first subject in HCM drug trial
    May 6 Edgewise Therapeutics Doses First Patient in Phase 2 CIRRUS-HCM Trial of EDG-7500 in Obstructive Hypertrophic Cardiomyopathy (HCM)
    See more EWTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 21.6
    52 Week Low 5.12
    Average Volume 617,906
    200-Day Moving Average 11.95
    50-Day Moving Average 17.42
    20-Day Moving Average 18.37
    10-Day Moving Average 17.64
    Average True Range 1.00
    RSI (14) 45.05
    ADX 12.63
    +DI 20.53
    -DI 19.36
    Chandelier Exit (Long, 3 ATRs) 18.60
    Chandelier Exit (Short, 3 ATRs) 19.63
    Upper Bollinger Bands 20.94
    Lower Bollinger Band 15.81
    Percent B (%b) 0.26
    BandWidth 27.92
    MACD Line -0.11
    MACD Signal Line 0.09
    MACD Histogram -0.1963
    Fundamentals Value
    Market Cap 1.58 Billion
    Num Shares 92.3 Million
    EPS -1.40
    Price-to-Earnings (P/E) Ratio -12.24
    Price-to-Sales 0.00
    Price-to-Book 6.29
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 18.44
    Resistance 3 (R3) 18.56 18.23 18.22
    Resistance 2 (R2) 18.23 17.90 18.17 18.15
    Resistance 1 (R1) 17.68 17.69 17.52 17.57 18.08
    Pivot Point 17.36 17.36 17.27 17.30 17.36
    Support 1 (S1) 16.81 17.02 16.64 16.69 16.18
    Support 2 (S2) 16.48 16.81 16.42 16.11
    Support 3 (S3) 15.93 16.48 16.04
    Support 4 (S4) 15.82